Morgan Stanley 4Q earnings smash Wall Street forecasts as revenue jumps across the board
Morgan Stanley posted fourth-quarter earnings on Thursday that smashed Wall Street's revenue and profit forecasts.The bank delivered record revenue and net income last year.Morgan Stanley posted fourth-quarter earnings on Thursday that smashed Wall Street's revenue and profit forecasts, according to a Bloomberg survey of analysts.
"Firmwide revenues were over $10 billion for the fourth consecutive quarter, resulting in record full year revenues and net income. This consistent performance met all of our stated performance targets."
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Morgan Stanley is set to report fourth-quarter earnings – here's what the Street expectsDid Morgan Stanley's bond traders match the performance of rivals – or get beaten by them?
Read more »
Morgan Stanley has promoted 130 new managing directors for its 2020 class - Business InsiderThat's fewer new MD promotions than in recent years at the investment bank, which has been cutting costs and jobs in recent months.
Read more »
Morgan Stanley earnings, retail sales, manufacturing gauge: 3 things to watch for in the markets ThursdayWe'll get earnings from Morgan Stanley, retail sales and Philadelphia Federal Reserve manufacturing index results on Thursday.
Read more »
Tesla shares fall after Morgan Stanley recommends dumping the stock. Here are the detailsMorgan Stanley downgraded the company to underweight and urged clients to wait for a better entry point to buy the stock.
Read more »
JP Morgan admits to `terrible customer experience' in response to discrimination allegationsA newspaper article about racial discrimination sent shock waves throughout J.P. Morgan, the biggest U.S. lender with 257,000 employees.
Read more »
Confusion and hype over 'digital health' overshadows J.P. Morgan health conferenceOther big topics at this week's J.P. Morgan Healthcare Conference in San Francisco included the lack of diversity at the executive ranks, drug pricing, big tech's march into the sector, and the missing patient voice.
Read more »